Bandingkan Harga & Kinerja Techno9 Indonesia Tbk. (NINE) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Techno9 Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Techno9 Indonesia Tbk. diperdagangkan di Rp94 (kapitalisasi pasar 202,76 M, volume 24 jam 4,67 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Techno9 Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| NINE | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 202,76 M | 104,4 M |
Volume | 4,67 jt | — |
Lot | 46,7 rb | — |
Perputaran | 436,03 jt | — |
Harga Rata-rata | 93,36 | — |
Nilai Transaksi | 436,03 jt | — |
Harga Ekuilibrium Indikatif | 94 | — |
Volume Ekuilibrium Indikatif | 1,4 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Techno9 Indonesia Tbk.
PT Techno9 Indonesia,Tbk (the"Company")wasestablished based on Deed No. 05 dated June 9, 2010, whichwasmade before Notary Lidya Enywati Tjendra, S.H. The Company started its commercial operations since June 23, 2010
Selengkapnya di halaman NINE →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
